is glutathione carcinogenic Tumor-targeted oxidation catalysis with ruthenium nanoreactors against hypoxic osteosarcoma Metabolic activation of benzo[a]pyrene into
Pay in 4 interest-free payments of $7.39 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
![is glutathione carcinogenic Tumor-targeted oxidation catalysis with ruthenium nanoreactors against hypoxic osteosarcoma Metabolic activation of benzo[a]pyrene into](https://www.researchgate.net/publication/306423566/figure/fig14/AS:398612568789008@1472048050941/Metabolic-activation-of-benzoapyrene-into-a-carcinogenic-metabolite-and-detoxification.png)
![is glutathione carcinogenic Tumor-targeted oxidation catalysis with ruthenium nanoreactors against hypoxic osteosarcoma Metabolic activation of benzo[a]pyrene into](https://www.researchgate.net/publication/341563764/figure/fig5/AS:11431281178959909@1691141356094/Significance-of-ferroptosis-in-carcinogenesis-and-tumor-biology-GPX4-glutathione.png)
![is glutathione carcinogenic Tumor-targeted oxidation catalysis with ruthenium nanoreactors against hypoxic osteosarcoma Metabolic activation of benzo[a]pyrene into](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs12013-026-02018-y/MediaObjects/12013_2026_2018_Fig1_HTML.png)